154 related articles for article (PubMed ID: 8848524)
1. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.
Nordin C; Almé B; Bondesson U
Psychopharmacology (Berl); 1995 Nov; 122(2):104-7. PubMed ID: 8848524
[TBL] [Abstract][Full Text] [Related]
2. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
4. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
5. Small effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders.
Facciolà G; Avenoso A; Scordo MG; Madia AG; Ventimiglia A; Perucca E; Spina E
Ther Drug Monit; 1999 Jun; 21(3):341-5. PubMed ID: 10365650
[TBL] [Abstract][Full Text] [Related]
6. Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia.
Ismail Z; Wessels AM; Uchida H; Ng W; Mamo DC; Rajji TK; Pollock BG; Mulsant BH; Bies RR
Am J Geriatr Psychiatry; 2012 Jan; 20(1):53-60. PubMed ID: 21422906
[TBL] [Abstract][Full Text] [Related]
7. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
Ming DS; Heathcote J
J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
[TBL] [Abstract][Full Text] [Related]
9. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia.
Raaska K; Raitasuo V; Neuvonen PJ
Eur J Clin Pharmacol; 2001 Dec; 57(10):705-8. PubMed ID: 11829199
[TBL] [Abstract][Full Text] [Related]
10. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
[TBL] [Abstract][Full Text] [Related]
11. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
Flanagan RJ; Amin A; Seinen W
Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.
Tan MSA; Honarparvar F; Falconer JR; Parekh HS; Pandey P; Siskind DJ
Psychopharmacology (Berl); 2021 Mar; 238(3):615-637. PubMed ID: 33410989
[TBL] [Abstract][Full Text] [Related]
13. Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
Dettling M; Sachse C; Brockmöller J; Schley J; Müller-Oerlinghausen B; Pickersgill I; Rolfs A; Schaub RT; Schmider J
Psychopharmacology (Berl); 2000 Sep; 152(1):80-6. PubMed ID: 11041319
[TBL] [Abstract][Full Text] [Related]
14. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
15. Distribution of clozapine and desmethylclozapine between blood and brain in rats.
Weigmann H; Härtter S; Fischer V; Dahmen N; Hiemke C
Eur Neuropsychopharmacol; 1999 Mar; 9(3):253-6. PubMed ID: 10208296
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of clozapine and N-desmethylclozapine are unaffected by the potent CYP3A4 inhibitor itraconazole.
Raaska K; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Apr; 54(2):167-70. PubMed ID: 9626923
[TBL] [Abstract][Full Text] [Related]
17. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
Ruan CJ; Olmos I; Ricciardi C; Schoretsanitis G; Vincent PD; Anıl Yağcıoğlu AE; Eap CB; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Every-Palmer S; Procyshyn RM; Rohde C; Suhas S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; Molden E; De Las Cuevas C; de Leon J
Schizophr Res; 2024 Jun; 268():293-301. PubMed ID: 37487869
[TBL] [Abstract][Full Text] [Related]
18. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
[TBL] [Abstract][Full Text] [Related]
19. The significance of sampling time in therapeutic drug monitoring of clozapine.
Jakobsen MI; Larsen JR; Svensson CK; Johansen SS; Linnet K; Nielsen J; Fink-Jensen A
Acta Psychiatr Scand; 2017 Feb; 135(2):159-169. PubMed ID: 27922183
[TBL] [Abstract][Full Text] [Related]
20. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
